-+ 0.00%
-+ 0.00%
-+ 0.00%

Calidi Biotherapeutics Q2 EPS $(2.94) Down From $(1.99) YoY

Benzinga·08/13/2026 20:41:20
语音播报
Calidi Biotherapeutics (AMEX:CLDI) reported quarterly losses of $(2.94) per share. This is a 47.74 percent decrease over losses of $(1.99) per share from the same period last year.